# Graxcell USA, LLC - Inspection Records

Source: https://www.keypedia.com/companies/graxcell-usa-llc/ab57492b-f255-40e5-8920-60a0daa5f859

> Inspection records and compliance data for Graxcell USA, LLC in Paulsboro, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Graxcell USA, LLC
- FEI Number: 3013737587
- City: Paulsboro
- State: New Jersey
- Country Name: United States
- Address Line 1: 650 Grove Rd Ste 108
- Zip Code: 08066

## Related Documents

- [FDA Inspection 1070902 - Graxcell USA, LLC - 2018-11-05](https://www.keypedia.com/records/fda_inspections/graxcell-usa-llc/6fc5028a-2213-4195-a0b4-08960ef6df28) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 5, 2018

## Related Companies

- [Universal Farma SL](https://www.keypedia.com/companies/universal-farma-sl/42c93632-bd91-4c65-a64e-6f4d2045df00)
- [Alexza Pharmaceuticals, Inc.](https://www.keypedia.com/companies/alexza-pharmaceuticals-inc/4b71680e-1a0e-4237-8b2a-2e2c32c5c8fe)
- [Apotex, Inc.](https://www.keypedia.com/companies/apotex-inc/3fb3d66a-fef9-4c47-82b5-da446ecf3593)
- [ENDO USA, Inc](https://www.keypedia.com/companies/endo-usa-inc/f9a78673-fb86-4980-bb89-72259da48fb9)
- [Sterigenics Belgium Petit-Rechain S.A.](https://www.keypedia.com/companies/sterigenics-belgium-petit-rechain-sa/dbfccd17-4f8c-42ad-8616-9fdf022cd954)
- [Forest Laboratories Ireland Limited](https://www.keypedia.com/companies/forest-laboratories-ireland-limited/6d308a71-830b-4cbc-9314-2a44f9290d1f)
- [Otsuka Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/otsuka-pharmaceutical-co-ltd/5a397250-e719-4d0b-9a66-64f88d34da89)
- [SWISSCAPS Romania SRL](https://www.keypedia.com/companies/swisscaps-romania-srl/16482726-eaba-4a39-bbc5-b0861409684f)
- [Catalent Germany Eberbach GmbH](https://www.keypedia.com/companies/catalent-germany-eberbach-gmbh/fcf97f2a-c54b-4105-afc0-11a0c999d8a5)
- [Excite Pharma Services LLC](https://www.keypedia.com/companies/excite-pharma-services-llc/05ab029c-7828-4cd1-87f5-0b05fb0b7db1)
